COMMUNIQUÉS West-GlobeNewswire

NEXSTIM PLC’S FINANCIAL STATEMENTS BULLETIN 2023
27/02/2024
Company announcement, Helsinki 27 February 2024 at 9 am (EET) NEXSTIM PLC’S FINANCIAL STATEMENTS BULLETIN 2023 NEXSTIM CONTINUED TO GROW COMPARABLE NET SALES WITH A RECORD YEAR-END July–December 2023 The company’s net [...]
Zealand Pharma convenes its Annual General Meeting 2024
27/02/2024
Company Announcement – No. 10 / 2024 Zealand Pharma convenes its Annual General Meeting 2024 Notice to convene the Annual General Meeting of Zealand Pharma A/S (CVR no. 20 04 50 78) (the "Company"). The Board of [...]
Zealand Pharma Announces Financial Results for the Full Year 2023
27/02/2024
Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a solid financial position [...]
Alira Health publie le rapport mondial 2024 sur la fabrication sous contrat dans le secteur des technologies médicales
27/02/2024
En 2023, le marché mondial de l’externalisation des technologies médicales, dites medtech, a progressé de plus de 11 % pour atteindre 81,5 milliards de dollars, ce qui témoigne d’une forte résilience du marché [...]
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
27/02/2024
Media Release COPENHAGEN, Denmark; February 27, 2024 FDA grants Priority Review with target action date of June 28, 2024 Application based on results from Phase 1/2 EPCORE™ NHL-1 trial demonstrating clinically [...]
Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
27/02/2024
Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease PALO ALTO, Calif., and ZHUHAI, China, Feb. 26, 2024 (GLOBE NEWSWIRE [...]
RTG Medical Ranks #70 on Inc. 5000 Regionals List in the Midwest
27/02/2024
FREMONT, Neb., Feb. 26, 2024 (GLOBE NEWSWIRE) -- RTG Medical, a leading healthcare staffing agency, has been recognized as one of the top performers in the Midwest, securing the impressive #70 spot on the prestigious [...]
Ibogaine Treatment May Be More Effective During the Month of March, According to David Dardashti
26/02/2024
Miami, FL - Ibogaine by David Dardashti Suggests Theory Behind the Theory MIAMI, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Mental health advocate David Dardashti has suggested that the month of March may be the most effective [...]
Premier Health Reports 2024 First Quarter Results
26/02/2024
MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Corporation ”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial [...]
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
26/02/2024
PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid [...]
Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
26/02/2024
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) [...]
Teladoc Health to Participate in Upcoming Investor Conference
26/02/2024
PURCHASE, NY, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that Mala Murthy, chief financial officer, will participate in the TD [...]
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
26/02/2024
PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023 with $366.3 million [...]
Travere Therapeutics to Present at Upcoming Investor Conferences
26/02/2024
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will participate in the following upcoming investor conferences in March: Cowen 44 th Annual [...]
Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics
26/02/2024
MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC ( [...]
HWH International Inc. Acquires Café in South Korea, Unveiling Second Hapi Cafe Outlet
26/02/2024
Bethesda, MD, Feb. 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) proudly announces the acquisition of a café in Seocho-gu, South Korea, marking the launch of its second Hapi Cafe outlet in [...]
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
26/02/2024
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results [...]
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
26/02/2024
• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246 in metastatic castration-resistant prostate cancer (mCRPC) expected [...]
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
26/02/2024
Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing [...]

Pages